Natco Pharma Q3 net profit rises over two-fold to Rs 37.15 cr
Advertisement
New Delhi: Drug firm Natco Pharma reported over two-fold jump in consolidated net profit at Rs 37.15 crore for the third quarter ended December 2015.
The company had posted a net profit of Rs 14.34 crore during the same quarter of the previous fiscal as it was hit by a one-off item of Rs 1,513 crore paid for settlement of a legal dispute.
Net sales of the company also increased by 42.79 per cent to Rs 263.12 crore during the period under review as against Rs 184.27 crore in the same period last fiscal, Natco Pharma said in a BSE filing.
In a separate filing, the company informed that its board has recommended an interim dividend of Rs 1.25 per equity share.
The company had posted a net profit of Rs 14.34 crore during the same quarter of the previous fiscal as it was hit by a one-off item of Rs 1,513 crore paid for settlement of a legal dispute.
Net sales of the company also increased by 42.79 per cent to Rs 263.12 crore during the period under review as against Rs 184.27 crore in the same period last fiscal, Natco Pharma said in a BSE filing.
In a separate filing, the company informed that its board has recommended an interim dividend of Rs 1.25 per equity share.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.